Page 2 - Shell Asset Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shell asset management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shell Asset Management Today - Breaking & Trending Today

CIBC Boosts Celestica (NYSE:CLS) Price Target to $58.00

Celestica (NYSE:CLS – Free Report) (TSE:CLS) had its price objective hoisted by CIBC from $49.00 to $58.00 in a report published on Monday morning, BayStreet.CA reports. The firm currently has a neutral rating on the technology company’s stock. A number of other research analysts have also weighed in on CLS. TD Securities increased their price […] ....

United States , Stifel Nicolaus , Jetstream Capital , Canaccord Genuity Group , American Century Companies Inc , Celestica Inc , Shell Asset Management Co , Vanguard Group Inc , Connectivity Cloud Solutions , Technology Solutions , Free Report , Genuity Group , Moderate Buy , Get Free Report , Century Companies , Shell Asset Management , Asset Management , North America , Advanced Technology Solutions , Celestica Daily ,

Ruffer LLP Takes $261,000 Position in Nutrien Ltd. (NYSE:NTR)

Ruffer LLP Takes $261,000 Position in Nutrien Ltd. (NYSE:NTR)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Piper Sandler , Nutrien Company Profile , Goldman Sachs Group , Berenberg Bank , Capital Investment Counsel Inc , Royal Bank , Shell Asset Management Co , Nutrien Ltd , Ruggaard Associates , Exchange Commission , Free Report , Pacific Financial , Investment Counsel Inc , Shell Asset Management , Asset Management , Get Free Report , Visit Holdingschannel , Nutrien Daily ,

Analysts Set ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Price Target at $28.94

Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the sixteen ratings firms that are currently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating on the company. The average twelve-month […] ....

United States , Stifel Nicolaus , Markc Schneyer , Brendan Teehan , Pharmaceuticals Price Performance , Shell Asset Management Co , Securities Exchange Commission , Jpmorgan Chase Co , Pharmaceuticals Daily , Pharmaceuticals Inc , Quest Partners , Covestor Ltd , Headlands Technologies , Get Free Report , Exchange Commission , Management Fondsmaeglerselskab , Shell Asset Management , Asset Management , Get Free ,

Eldorado Gold Co. (NYSE:EGO) Shares Sold by Franklin Resources Inc.

Franklin Resources Inc. lowered its holdings in Eldorado Gold Co. (NYSE:EGO – Free Report) (TSE:ELD) by 25.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,295,988 shares of the basic materials company’s stock after selling 435,432 shares during the quarter. Franklin Resources Inc. owned […] ....

Perifereia Peloponnisou , Perifereia Anatolikis Makedonias Kai Thrakis , Perama Hill , Franklin Resources Inc , Eldorado Gold , Atria Wealth Solutions Inc , Parkside Financial Bank , Shell Asset Management Co , National Bank Financial , Eldorado Gold Co , Eldorado Gold Corporation , Franklin Resources , Free Report , Financial Bank , Wealth Solutions , Nova Scotia , Shell Asset Management , Asset Management , Bank Financial , Get Free Report , Gold Corporation , Eldorado Gold Daily ,

ACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 52-Week Low at $14.60

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $14.60 and last traded at $14.68, with a volume of 628880 shares traded. The stock had previously closed at $15.09. Analysts Set New Price Targets Several brokerages have […] ....

United States , James Kihara , Markc Schneyer , Jpmorgan Chase Co , Shell Asset Management Co , Covestor Ltd , Headlands Technologies , Quest Partners , Pharmaceuticals Daily , Pharmaceuticals Inc , Pharmaceuticals Price Performance , Royal Bank , Acadia Pharmaceuticals Inc , Get Free Report , Management Fondsmaeglerselskab , Shell Asset Management , Asset Management ,